Atlas Trials

Aura Biosciences

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aura Biosciences

RecordFirmDate
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma (NCT07338968)Aura Biosciences2026-02-01
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects (NCT07421739)Aura Biosciences2025-11-12
Suprachoroidal Administration in Subjects With Metastases to the Choroid (NCT06643884)Aura Biosciences2024-12-16
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (NCT06007690)Aura Biosciences2023-12-06
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer (NCT05483868)Aura Biosciences2022-09-26
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma (NCT04417530)Aura Biosciences2020-08-05
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma (NCT03941379)Aura Biosciences2019-03-27

Track Aura Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.